discoverIE Group

FY24 EPS in line; good margin progress

Electronics & Electrical Equipment | 19/04/2024
Ultimovacs

Steadfast commitment to UV1 progression

Pharmaceuticals & healthcare | 18/04/2024
OSE Immunotherapeutics

AbbVie deal clears antitrust hurdle

Pharmaceuticals & healthcare | 18/04/2024
Foxtons Group

FY24 underpinned by market share gains

Property | 18/04/2024
Jersey Electricity

Decarbonisation fuelling growth

General Industrials | 18/04/2024
Manx Financial Group

Executing on a high-growth strategy

Financials | 18/04/2024
Carr's Group

An enhanced value creation strategy

Consumer staples | 18/04/2024
Arcadium Lithium

When one plus one equals three

Mining | 17/04/2024
ABO Energy

Global growth generates record net profit

Alternative Energy | 17/04/2024
Next 15 Group

Baked in AI opportunities

Media | 17/04/2024
Severfield

Multiple positives should excite investors

General Industrials | 17/04/2024
IP Group

Several potential portfolio catalysts on the horizon

Technology | 16/04/2024
Actinogen Medical

First patient dosed in Phase IIb XanaMIA study

Pharmaceuticals & healthcare | 16/04/2024
Cereno Scientific

CS014 (thrombosis) progresses towards the clinic

Pharmaceuticals & healthcare | 16/04/2024
Tetragon Financial Group

FY23 growth driven by idiosyncratic factors

Investment trusts | 16/04/2024
Cloudberry Clean Energy

Transformative FY23 with revenue rocketing

Alternative Energy | 16/04/2024
Arctic Paper

FY23 focused on margin management

Basic Industries | 16/04/2024
Domino's Pizza

Growing the base

Food & Drink | 16/04/2024
Checkit

New product launch and contract wins

Technology | 15/04/2024
abrdn Asian Income Fund

All looking good in terms of income and growth

Investment trusts | 15/04/2024
Murray Income Trust

Delivering income and capital growth

Investment trusts | 15/04/2024
VietNam Holding

Introducing redeemable shares

Investment trusts | 12/04/2024
OSE Immunotherapeutics

Funding accelerates Tedopi clinical development

Pharmaceuticals & healthcare | 12/04/2024
EML Payments

Cutting the final link to PFS vendors

Technology | 12/04/2024
Lowland Investment Company

Is the tide turning?

Investment trusts | 12/04/2024
Norcros

FY24 trading in line with expectations

Construction & Building Materials | 12/04/2024
Ocean Harvest Technology

Harvesting the power of seaweed

General Retailers | 11/04/2024
M&C Saatchi

Moving into alignment

Media | 11/04/2024
Seraphim Space Investment Trust

Several key holdings funded to break-even

Investment trusts | 10/04/2024
Utilico Emerging Markets Trust

Quality of UEM’s assets is underappreciated

Investment trusts | 10/04/2024
Basilea Pharmaceutica

CARB-X grant for preclinical programs

Pharmaceuticals & healthcare | 10/04/2024
ADS-TEC Energy

Serving the energy transition

Industrial Support Services | 09/04/2024
Regional REIT

Performing as expected ahead of refinancing

Property | 09/04/2024
Premier Miton Global Renewables Trust

Deep dive on developers

Investment trusts | 09/04/2024
Picton Property Income

Accretive portfolio repositioning

Property | 09/04/2024
Oryzon Genomics

FDA green light for SCLC combination trial

Pharmaceuticals & healthcare | 09/04/2024
JDC Group

Accelerating again in FY24

Financials | 08/04/2024
MGI - Media and Games Invest

Google strategic collaboration

Technology | 08/04/2024
IRLAB Therapeutics

Beyond PD-LID, a closer look at PD-psychosis

Pharmaceuticals & healthcare | 08/04/2024
AUSTRIACARD

Holding a strong hand

Technology | 05/04/2024
Oryzon Genomics

Third time is a charm; INNOVATIVE SME Seal

Pharmaceuticals & healthcare | 05/04/2024
Mendus

Gross proceeds of c SEK69m to advance pipeline

Pharmaceuticals & healthcare | 04/04/2024
Helios Underwriting

Strong share price on supportive fundamentals

Financials | 04/04/2024
Basilea Pharmaceutica

Zevtera crosses key US regulatory hurdle

Pharmaceuticals & healthcare | 04/04/2024
Cadence Minerals

Amapá optimisation adds value

Mining | 04/04/2024
Altron

Rising star

Technology | 04/04/2024
SIGA Technologies

Positive signals abound

Pharmaceuticals & healthcare | 04/04/2024
Sareum Holdings

A decisive period ahead for SDC-1801

Pharmaceuticals & healthcare | 03/04/2024
The Metals Company

Growing up

Mining | 03/04/2024
Immix Biopharma

Reaffirmed long-term focus on outpatient CAR-T

Pharmaceuticals & healthcare | 03/04/2024
Cordel Group

Positive steps towards ambitious FY24 goals

Technology | 03/04/2024
Topps Tiles

Market tough through H124

Consumer Support Services | 03/04/2024
Solid State

Anticipating record adjusted PBT in FY24

General Industrials | 02/04/2024
Greggs

Showing us how it's done

Food & Drink | 02/04/2024
Information Services Corporation

A busy end to a record FY23

Industrial Support Services | 02/04/2024
OSE Immunotherapeutics

Pipeline momentum builds into FY24

Pharmaceuticals & healthcare | 02/04/2024
ABC arbitrage

FY23 results in line with market conditions

Financials | 28/03/2024
Gym Group

The power of marginal gains

Travel & Leisure | 28/03/2024
Mendus

Regulatory green light for CADENCE trial

Pharmaceuticals & healthcare | 28/03/2024
Alpha Bank

Full steam ahead

Financials | 28/03/2024
Dalata Hotel

A strong hand

Travel & Leisure | 28/03/2024
S4 Capital

Extension of recovery horizon

Media | 28/03/2024
Datatec

FY24 revenue growth of 5.8%

Technology | 27/03/2024
AG Barr

Fizzing away

Consumer staples | 27/03/2024
Kolibri Global Energy

FY23 reserves show solid replacement rates

Oil & gas | 27/03/2024
Recce Pharmaceuticals

R&D advance (A$11.18m) extends runway

Pharmaceuticals & healthcare | 26/03/2024
Immix Biopharma

Marching towards US clinical trials for NXC-201

Pharmaceuticals & healthcare | 26/03/2024
Ocean Wilsons Holdings

Strong FY23 results with strategic review in FY24

Investment trusts | 25/03/2024
Kinepolis

On the move

Travel & Leisure | 25/03/2024
IRLAB Therapeutics

FDA thumbs up to mesdopetam’s Phase III plan

Pharmaceuticals & healthcare | 25/03/2024
Nano Dimension

Growth in a tough market

Technology | 25/03/2024
Northern Data Group

First transparency milestone achieved

Technology | 25/03/2024
Quadrise

Funding the gap to commercial revenues

General Industrials | 25/03/2024
Greencoat Renewables

Acquisitions generating more green

Alternative Energy | 25/03/2024
Henderson EuroTrust

Proposed merger with Henderson European Focus Trust

Investment trusts | 22/03/2024
HgT

Strong earnings growth and realisations in FY23

Investment trusts | 22/03/2024
Ascential

Clarity and focus on key platforms

Media | 22/03/2024
Vantiva

Termination of coverage

Technology | 22/03/2024
Orrön Energy

Capitalising on renewable ambitions

Alternative Energy | 22/03/2024
ReNeuron Group

Termination of coverage

Pharmaceuticals & healthcare | 22/03/2024
Respiri

Termination of coverage

Pharmaceuticals & healthcare | 22/03/2024
LXi REIT

Termination of coverage

Property | 22/03/2024
Round Hill Music Royalty Fund

Termination of coverage

Investment trusts | 22/03/2024
EQS Group

Termination of coverage

Media | 22/03/2024
ACWA Power

Record results for FY23

Industrial Support Services | 22/03/2024
Triple Point Social Housing REIT

Financial and operational progress

Property | 22/03/2024
Games Workshop Group

Steady as she goes

Consumer Support Services | 22/03/2024
Foxtons Group

Medium-term targets come into view

Property | 21/03/2024
Dowlais Group

Motoring forward

Industrial Support Services | 21/03/2024
Murray International Trust

Business as usual ahead of manager’s retirement

Investment trusts | 21/03/2024
The Pebble Group

Positioned to benefit from re-emerging confidence

Media | 21/03/2024
Braemar

Diversification paying dividends

Industrial Support Services | 20/03/2024
Boku

Making the complex simple for global merchants

Technology | 20/03/2024
Tinexta

Strongest year since FY18

Technology | 20/03/2024
IRLAB Therapeutics

Mesdopetam’s potential highlighted in PD-psychosis

Pharmaceuticals & healthcare | 20/03/2024
Newron Pharmaceuticals

Evenamide set for a pivotal year

Pharmaceuticals & healthcare | 20/03/2024
The Biotech Growth Trust

Onwards and upwards for performance recovery

Investment trusts | 20/03/2024
Team Internet Group

Growth and returns, acquisition bolsters outlook

Technology | 19/03/2024
OPAP

A good end to FY23

Travel & Leisure | 19/03/2024
OSE Immunotherapeutics

One step closer to key data readouts

Pharmaceuticals & healthcare | 19/03/2024